好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Effectiveness, Relevance, and Feasibility of an Online Course on Multiple Sclerosis for African Healthcare Workers
Multiple Sclerosis
P4 - Poster Session 4 (5:00 PM-6:00 PM)
1-009

 To evaluate the effectiveness of an MS online course in enhancing African healthcare workers in understanding MS symptoms, diagnosing and management

 

Multiple Sclerosis (MS) diagnosis and management pose significant challenges in low- and middle-income countries (LMICs), especially in Africa, where awareness and resources for its management are limited.

A five-day virtual MS course was conducted via Zoom, engaging almost 800 participants from 36 countries, including 22 African countries. The course featured tailored content for healthcare professionals in resource-limited settings, with specific sessions for ophthalmologists and neurosurgeons. Pre- and post-course surveys assessed participants' familiarity with MS, confidence in diagnosing the condition, and the relevance of the course to their clinical practice

398 participants completed the pre-course survey (51.4% female; 37.8% general practitioners, 28.2% internal medicine physicians, and 15.5% neurologists), while 301 completed the pre-course knowledge assessment, 221 completed the post-course survey, and 112 completed the post-course knowledge assessment. Mean knowledge assessment score improved from 9.9±2.8 (range: 3-16; total possible: 16) to 12.1±2.8 (range; 4-16) (p< 0.001), demonstrating a significant improvement in knowledge. Additionally, pre,- and post-course analysis revealed statistically significant improvements in familiarity with MS symptoms (mean pre: 2.9±0.1 versus post: 3.8±0.1, p < 0.001), confidence in diagnosing MS (mean pre: 2.6±0.1 versus post: 3.7±0.1. p < 0.001), and knowledge of MS management (mean pre: 2.5±0.1 vs post: 3.5±0.1, p < 0.001). Satisfaction with the course was high, with 95% of participants rating the material as highly relevant to MS care in Africa. Additionally, 97% expressed interest in attending similar future courses and would recommend the course to colleagues.
This virtual  course significantly enhanced healthcare workers' understanding of MS symptoms, diagnosis, and management in African contexts. The course was regarded as both relevant and feasible, underscoring the potential of virtual platforms to bridge the MS knowledge and training gap in LMICs
Authors/Disclosures
Fiifi Duodu, MD (Korle-Bu Teaching Hospital Medical department)
PRESENTER 		Dr. Duodu has nothing to disclose.
Alexandra C. Simpson, MD (Johns Hopkins Hospital) Dr. Simpson has received research support from National MS Society.
Riadh Gouider, MD, FAAN (Erazi Hospital) Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hikma. The institution of Dr. Gouider has received research support from Clinical Investigation Center. The institution of Dr. Gouider has received research support from Menactrims.
Jacqueline Mavuti, MBChB Dr. Mavuti has nothing to disclose.
Dickson Munkombwe, MD (University Teaching Hospital - Adult Hospital) Dr. Munkombwe has nothing to disclose.
Frighton B. Mutete, MBChB (Livingstone University Teaching Hospital) Dr. Mutete has nothing to disclose.
Dilraj S. Sokhi, FRCP (Aga Khan University Medical College of East Africa, Nairobi Campus) The institution of Dr. Sokhi has received research support from Genentech.
NAA NAAMUAH N. TAGOE, MD Dr. TAGOE has nothing to disclose.
Chimozi S. Tembo, MD Dr. Tembo has nothing to disclose.
Mashina Chomba, MBChB (University of Zambia) Dr. Chomba has nothing to disclose.
Deanna Saylor, MD, MHS (Johns Hopkins Hospital) Dr. Saylor has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from 好色先生. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and 好色先生al Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities.